Intan Sofia Omar. (2022). Abnormal progesterone receptor signaling in endometrial cancer-associated fibroblasts contributes to medroxyprogesterone acetate resistance in endometrial cancer: Intan Sofia Omar.
Chicago Style (17th ed.) CitationIntan Sofia Omar. Abnormal Progesterone Receptor Signaling in Endometrial Cancer-associated Fibroblasts Contributes to Medroxyprogesterone Acetate Resistance in Endometrial Cancer: Intan Sofia Omar. 2022.
MLA引文Intan Sofia Omar. Abnormal Progesterone Receptor Signaling in Endometrial Cancer-associated Fibroblasts Contributes to Medroxyprogesterone Acetate Resistance in Endometrial Cancer: Intan Sofia Omar. 2022.
警告：這些引文格式不一定是100％准確.